Ten years after its debut, Monster Strike gets a new anime adaptation in Monster Strike: Deadverse Reloaded, bringing the ...

Stephen Graham's punchy Peaky Blinders replacement, A Thousand Blows, returns with a must-watch Season 2 trailer. Watch it ...

Adults season 2 is coming in 2026. Adults is about a group of 20-somethings who are just trying to figure out how to be, well ...

SteelSeries Arctis Nova 7 Gen 2 delivers real-time audio control, 200+ game presets, dual 2.4GHz & Bluetooth, 54-hour battery, and multi-platform support — all for $199. SteelSeries helped define what ...

Gege Akutami’s Jujutsu Kaisen stands out as a true new-gen shonen series by breaking many of the genre’s molds. However, in doing so, the series has caused several issues. Jujutsu Kaisen doesn’t seem ...

The Seattle Mariners could not have scripted this any better. After rallying to win Sunday's Game 1, the Mariners teed off on Toronto pitching Monday, securing a 10-3 win over the Blue Jays in Game 2 ...

It was clear from the get go that Game 2 of the American League Championship Series was going to look quite different than what was seen Sunday night. There were more runs scored by the end of the ...

Apple is expected to release a second-generation Apple Pro Display XDR in the near future, and it looks like it will include an important component missing from the original $5000 monitor. Based on ...

“X-Men ’97” has been renewed for Season 3, it was announced at New York Comic Con on Saturday. Season 2 will release in summer 2026. A trailer shown in the room to Comic Con attendees showed the ...

The Chicago Blackhawks hosted the Montreal Canadiens tonight in the Blackhawks’ home opener celebrating the team’s centennial season. The Blackhawks were looking for their first win of the season, ...

Fans of the Dexter Morgan universe got some killer news this week as the franchise’s latest series has been renewed for a second season. Star Michael C. Hall -- who portrays Morgan -- announced the ...

Expedition Therapeutics is gearing up for a phase 2 trek with a $165 million series A that closed Oct. 9. The new funding will fuel the Bay Area biotech’s DPP1 inhibitor EXPD-101 as it ventures into a ...